Related Experiment Videos
Tubulointerstitial nephritis associated with pyrazinamide.
The Netherlands Journal of Medicine
|February 1, 1989
Summary
Pyrazinamide, a tuberculosis drug, may cause kidney failure. A patient experienced renal failure during treatment, which improved after stopping pyrazinamide, suggesting a link between this drug and kidney injury.
Area of Science:
- Nephrology
- Pharmacology
- Infectious Diseases
Background:
- Antitubercular therapy often involves multiple drugs, with some known to affect kidney function.
- Pyrazinamide is associated with potential side effects like liver toxicity and joint pain.
Observation:
- A patient undergoing treatment with isoniazid, rifampicin, streptomycin, and pyrazinamide developed renal failure, fever, arthritis, and arthralgia.
- Renal biopsy revealed tubulo-interstitial nephritis.
Findings:
- Withdrawal of pyrazinamide, while maintaining other medications, led to improvement in renal function and histological findings.
- This suggests a direct association between pyrazinamide and the observed renal failure.
Implications:
- Pyrazinamide may be an underrecognized cause of drug-induced acute kidney injury in tuberculosis treatment.
- Clinicians should consider pyrazinamide as a potential cause of renal impairment in patients presenting with these symptoms.
- Further research is warranted to elucidate the precise mechanism of pyrazinamide-induced nephrotoxicity.